Conversely, the downregulation of miR‐100b and miR‐125 in HCC exosomes activates the IGF2/AKT/mTOR pathway, essential for maintaining the stemness of HCC cells [120]. The gene discussed is IGF2; the disease is hepatocellular carcinoma.